| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 09/29/2009 | CA2481263C Use of pyrimidine nucleotides for the treatment of affections of the peripheral nervous system |
| 09/29/2009 | CA2469350C 3-{4-methyl-3[methyl-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidin-1-yl}-3-oxo-propionitrile mono citrate salt |
| 09/29/2009 | CA2464042C Mptp affinity labels |
| 09/29/2009 | CA2457944C Polycyclic guanine phosphodiesterase v inhibitors |
| 09/29/2009 | CA2415354C Phospholipid derivatives of valproic acid and mixtures thereof |
| 09/29/2009 | CA2414586C Agent for therapeutic treatment of optic nerve diseases and the like |
| 09/29/2009 | CA2383983C Substituted indolealkanoic acids |
| 09/29/2009 | CA2375670C 5-phenyl-pyrimidine derivatives |
| 09/29/2009 | CA2371853C Heterocyclic benzenesulphonamide compounds as bradykinin antagonists |
| 09/29/2009 | CA2354621C Transparent transdermal nicotine delivery devices |
| 09/29/2009 | CA2353962C Selective 5-ht6 receptor ligands |
| 09/29/2009 | CA2347105C Controlled-release pharmaceutical composition with gastric residence |
| 09/29/2009 | CA2334923C Aryl substituted olefinic amines and their use as cholinergic receptors agonists |
| 09/29/2009 | CA2334730C Novel cyclosporins |
| 09/29/2009 | CA2318208C Piperidine and pyrrolidine derivatives comprising a nitric oxide donor for treating stress |
| 09/29/2009 | CA2310850C A covalent conjugate of clozapine with a fatty acid and its use for treating schizophrenia |
| 09/29/2009 | CA2299361C Use of consensus interferon in combination with il-1 receptor antagonist for treatment of patients afflicted with multiple sclerosis |
| 09/29/2009 | CA2289531C Composition and methods for treating alzheimer's disease and other amyloidoses |
| 09/29/2009 | CA2259148C Solid oral dosage forms of valsartan |
| 09/29/2009 | CA2255171C 1,3,8-triaza-spiro[4,5]decan-4-on derivatives |
| 09/29/2009 | CA2184297C Recombinant viruses coding for a glutamate decarboxylase (gad) activity |
| 09/24/2009 | WO2009117480A2 Histidine related compounds for identifying and blocking amyloid beta ion channels |
| 09/24/2009 | WO2009117418A2 Identification of micro-rnas involved in neuromuscular synapse maintenance and regeneration |
| 09/24/2009 | WO2009117127A2 Nerve repair with a hydrogel and optional adhesive |
| 09/24/2009 | WO2009117042A1 Use of pyrene to carry non-peptide agents across the blood brain barrier |
| 09/24/2009 | WO2009117041A2 Use of pyrene to carry peptides across the blood brain barrier |
| 09/24/2009 | WO2009116882A1 Crystal forms of 5- [3- (2, 5-dichloro-4, 6-dimethyl-1-oxy-pyridine-3-yl) [1,2,3] oxadiazol-5-yl] -3-nit robenzene-1, 2-diol |
| 09/24/2009 | WO2009116546A1 Excitatory chemical mediator and method for screening thereof |
| 09/24/2009 | WO2009115807A1 Inhibitors of the aryl hydrocarbon receptor for modulating the immune response |
| 09/24/2009 | WO2009115651A2 N-phenyl-imidazo[1,2-a]pyridine-2-carboxamide compounds, preparation thereof and therapeutic application thereof |
| 09/24/2009 | WO2009115634A1 Synergic 5'-methylthioadenosine combinations |
| 09/24/2009 | WO2009115547A1 Trisubstituted 1, 2, 4 -triazoiies as nicotinic acetylcholine receptor modulators |
| 09/24/2009 | WO2009115515A1 Arylsulfonyl pyrazoline carboxamidine derivatives as 5-ht6 antagonists |
| 09/24/2009 | WO2009115486A1 Triazole amide derivatives for use in therapy |
| 09/24/2009 | WO2009115427A1 Pyrrolidinyl derivatives and uses thereof |
| 09/24/2009 | WO2009115257A1 Substituted sulfonamide derivatives |
| 09/24/2009 | WO2009096817A3 Agent for reducing the degree of acute alcoholic intoxication (inebriation) and the use thereof |
| 09/24/2009 | WO2009094340A3 Omentum and use thereof |
| 09/24/2009 | WO2009087285A4 5,6-diaryl pyridines substituted in the 2- and 3-position, preparation thereof and therapeutic use thereof |
| 09/24/2009 | WO2009087212A3 Pyridine derivatives |
| 09/24/2009 | WO2009077559A3 5-oxo-3-pyrrolidinecarboxamide derivatives as p2x7 modulators |
| 09/24/2009 | WO2009068520A3 Polymorphic form of rotigotine |
| 09/24/2009 | WO2009065921A3 Novel compounds |
| 09/24/2009 | WO2009062750A3 Active soluble post-translationally modified neuregulin isoforms |
| 09/24/2009 | WO2009059755A3 Novel neurturin conjugates for pharmaceutical use |
| 09/24/2009 | WO2009053443A3 Indane compounds |
| 09/24/2009 | WO2009040068A3 Use of a peptide as a therapeutic agent |
| 09/24/2009 | WO2009040067A3 Use of a peptide as a therapeutic agent |
| 09/24/2009 | WO2009040049A3 Use of acetyl- (ala10, 11)-rantes (1-14) and/or calcitonin as anti-angiogenic agents |
| 09/24/2009 | WO2009033681A3 Cyclo-argd as a therapeutic agent |
| 09/24/2009 | WO2009033680A3 Galanin-like peptide alone or in combination with cyclo-argd as a therapeutic agent |
| 09/24/2009 | WO2009024611A3 4-benzylaminoquinolines, pharmaceutical compositions containing them and their use |
| 09/24/2009 | WO2008106657A3 Encapsulated amyloid-beta peptides |
| 09/24/2009 | US20090241205 Collapsin Response Mediator Protein, CRMP; lacosamide a new analgesic and antiepileptic agent, interacts with CRMP; drug screening, pharmacogenetics |
| 09/24/2009 | US20090240053 2-(4-(1-methyl-4-piperidinoxy)benzylamino)-2-methyl-propanamide; nervous system disorders; analgesics; anticonvulsants; sodium channel moderators; antidepressants, antiarrhythmics and for the treatment or prevention of diabetic neuropathy |
| 09/24/2009 | US20090239942 Topiramate Compositions and Methods of Making and Using the Same |
| 09/24/2009 | US20090239941 Amino acid derivatives |
| 09/24/2009 | US20090239929 N-Pyrrolidin-3-YL-Amide Derivatives As Serotonin and Noradrenalin Re-Uptake Inhibitors |
| 09/24/2009 | US20090239919 Glutamate receptor modulators and therapeutic agents |
| 09/24/2009 | US20090239917 Heterocyclic Cycloalkyl Compounds, a Process for their Preparation and Pharmaceutical Compositions Containing Them |
| 09/24/2009 | US20090239910 Benzenesulfonamide Compounds and Their Use |
| 09/24/2009 | US20090239908 Methods of treating psychosis and schizophrenia based on polymorphisms in the cntf gene |
| 09/24/2009 | US20090239903 Tetrahydroquinoline analogues as muscarinic agonists |
| 09/24/2009 | US20090239898 Further therapeutic use of zolpidem |
| 09/24/2009 | US20090239894 Stabilized aqueous solutions of ergoline compounds |
| 09/24/2009 | US20090239892 Pyridomorphinans, pyridazinomorphinans and use thereof |
| 09/24/2009 | US20090239890 Spiro substituted cyclopropane compounds for the treatment of inflammatory disorders |
| 09/24/2009 | US20090239888 Methods for Inhibiting Amyloid Precursor Protein and Beta-Amyloid Production and Accumulation |
| 09/24/2009 | US20090239877 Novel 1,2,4-triazole derivatives and process of manufacturing thereof |
| 09/24/2009 | US20090239875 Protection of ferulic acid and/or tetramethylpyrazine against retinal ischaemia, glaucoma and siderosis oculi |
| 09/24/2009 | US20090239874 Pyrido[3,2-e]pyrazines, their use as inhibitors of phospohodiesterase 10, and processes for preparing them |
| 09/24/2009 | US20090239873 Phenyl-piperazine derivatives as modulators of muscarinic receptors |
| 09/24/2009 | US20090239864 6- (pyridinyl) -4-pyrimidone derivates as tau protein kinase 1 inhibitors |
| 09/24/2009 | US20090239863 1-aryl-or 1- alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6 ligands |
| 09/24/2009 | US20090239855 Rapamycin Analogues and the Uses Thereof in the Treatment of Neurological, Proliferative, and Inflammatory Disorders |
| 09/24/2009 | US20090239854 Tetracyclic compounds |
| 09/24/2009 | US20090239853 Fused heterocycle derivative |
| 09/24/2009 | US20090239852 Use of oxicam compounds |
| 09/24/2009 | US20090239843 Bridged diazepan orexin receptor antagonists |
| 09/24/2009 | US20090239839 Receptor antagonist |
| 09/24/2009 | US20090239805 Human 3 relaxin |
| 09/24/2009 | US20090239783 Synergistic effects of combined administration of mirtazapine and a stimulant compound |
| 09/24/2009 | US20090239295 Dedifferentiated, Programmable Stem Cells of Monocytic Origin, and Their Production and Use |
| 09/24/2009 | US20090238886 Retro-Inversion Peptides That Target GIT Transport Receptors and Related Methods |
| 09/24/2009 | US20090238868 Abuse-resistant oral dosage forms and method of use thereof |
| 09/24/2009 | US20090238840 Therapeutic vaccine |
| 09/24/2009 | US20090238821 Humanized antibodies that sequester amyloid beta peptide |
| 09/24/2009 | US20090238803 Human cord blood derived unrestricted somatic stem cells (ussc) |
| 09/24/2009 | US20090238797 Nicotine-carrier vaccine formulation |
| 09/24/2009 | US20090238763 High penetration compositions and uses thereof |
| 09/24/2009 | US20090238761 Novel Aryl Piperazine Derivatives With Medical Utility |
| 09/24/2009 | DE102008015101A1 Kauzusammensetzung und deren Verwendung Kauzusammensetzung and their use |
| 09/24/2009 | CA2755492A1 Solid dosage form for treating headaches |
| 09/24/2009 | CA2718860A1 Use of pyrene to carry peptides across the blood brain barrier |
| 09/24/2009 | CA2718772A1 Crystal forms of 5-[3-(2,5-dichloro-4,6-dimethyl-1-oxy-pyridine-3-yl)[1,2,4]oxadiazol-5-yl]-3-nit robenzene-1,2-diol |
| 09/24/2009 | CA2718736A1 Pyrrolidinyl derivatives and uses thereof |
| 09/24/2009 | CA2718723A1 Novel compounds advantageous in the treatment of central nervous system diseases and disorders |
| 09/24/2009 | CA2718715A1 Nerve repair with a hydrogel and optional adhesive |
| 09/24/2009 | CA2718551A1 Substituted sulfonamide derivatives |
| 09/24/2009 | CA2718520A1 Identification of micro-rnas involved in neuromuscular synapse maintenance and regeneration |